Related Experiment Video
Updated: Aug 2, 2025

09:19
High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies
Published on: January 4, 2015
10.9K
Advancing cell therapy for neurodegenerative diseases.
1Neural Stem Cell Institute, Rensselaer, NY 12144, USA.
Cell Stem Cell
|April 21, 2023
Summary
Stem cell-derived therapies show promise for neurodegenerative diseases by targeting specific cell types. Understanding cellular roles in disease advances the development of effective cell-based treatments for the central nervous system (CNS).
Area of Science:
- Neuroscience
- Regenerative Medicine
- Cell Biology
Background:
- Neurodegenerative diseases impact the central nervous system (CNS).
- Genetic and single-cell studies are revealing the roles of specific cell types in neurodegenerative pathology.
- Emerging approaches aim to modulate cellular functions in disease.
Purpose of the Study:
- To review the advancement of cell products for neurodegenerative disease treatment.
- To examine how stem cell-derived CNS cell types contribute to therapeutic development.
- To highlight the importance of understanding cell-type-specific functions and pathology.
Main Methods:
- Review of current literature on stem cell-derived therapies for CNS disorders.
- Analysis of genetic and single-cell studies on neurodegenerative diseases.
- Examination of preclinical development of cell products.
Main Results:
- Stem cell technology enables the generation of diverse CNS cell types.
- Increased understanding of cellular contributions to neurodegeneration is driving therapeutic innovation.
- Preclinical development of cell products is advancing due to improved cellular insights.
Conclusions:
- The ability to generate specific CNS cell types from stem cells is crucial for developing effective treatments.
- A deeper understanding of cell-type-specific pathology is essential for advancing cell-based therapies.
- This review synthesizes current progress in preclinical cell product development for neurodegenerative diseases.
Keywords:
Alzheimer diseaseGABAergic neuronsParkinson diseaseage-related macular degenerationastrocytescentral nervous systemdopaminergic neuronsfrontotemporal dementiamicroglianeurodegenerative diseaseneuronsoligodendrocytesorganoidsphotoreceptorspreclinical studiesprogressive supranuclear palsyretinaretinal pigment epitheliumstem cell therapytransplantationRelated Concept Videos
Alzheimer's Disease: Treatment
230
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
230
iPS Cell Differentiation
2.8K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K
Stem Cell Therapy for Tissue Regeneration
4.1K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.1K
Parkinson's Disease: Overview
625
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
625
Gene Therapy
25.6K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.6K
Neurogenesis and Regeneration of Nervous Tissue
899
In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
899

